DOH try to catch up on contraceptives supply

HEALTH agencies here are rushing to distribute thousands of oral, subdermal, and other contraceptives after the order from the Food and Drug Administration (FDA) announcing the status of 51 brands as non-abortifacients.

In a telephone interview, Abdullah Dumama Jr., Department of Health assistant secretary for the Mindanao cluster, said the regional health units (RHUs) all over Davao Region are now rushing to implement the long-delayed distribution of the said items.

“Regionally, P3 million ang budget,” Dumama said about the items, which are centrally procured and downloaded to the RHUs.

For Region XI, the DOH here has around 1,000 combined cycles’ worth of oral contraceptives ready for distribution.

Aside from these are the 21,000 subdermal implants, 500 intrauterine devices, and 3,600 condoms ready for distribution for qualified clients.

Dumama added that the DOH central office has recently delivered allocations for the second semester to the RHUs.

Last week, the FDA announced the recertification of 51 products, after several pro-life groups accused the items of being abortifacients. The Supreme Court ruled that the FDA has the final say on the matter.

Cleared as non-abortifacients were the following pill, intrauterine device, and subdermal implant brands:

Cerazette, Estrelle, Exluton, Daphne, Leila, Implanon, Implanon NXT, Depo-gestin, Depo-gestin, Depofemme, Depotrust, Lyndavel, Protec, Depotrust, Mirena, Chloe, Althea, Cybelle, Estrelle Plus, Mercilon, Marvelon 28, Gracial, Liza, Lizonya, Yasmin, Lizelle, Yaz, Qlaira, Sophia, Meliane, Gynera, Julianne, Nordette, Lady, Denise, Minipil, Seif, Logynon 21, Protec, Famila 28F, Femme, Ruby, Trust Pill, Charlize, Zoely, Micropil, Micropil Plus, NORIFAM, Nuvaring, and Securit-T.

As of last week, the FDA said that the attached agency had already submitted its findings to the DOH.

Posted in Latest News